Ghana begins clinical trial of Nibima plant as herbal cure for Covid-19
London, Feb. 3, 2021 (AltAfrica)-The Ghana Food and Drugs Authority (FDA) together with the National Medicine Regulatory Agency (NMRA) has approved a herbal medicine Cryptolepis Sanguinolenta locally known as Nibima for clinical trials for the treatment of Covid-19.
In a statement cited by JoyNews, the FDA CEO indicated that the approval of the herbal medicine comes on the back of laboratory studies conducted by the Kwame Nkrumah University of Science and Technology (KNUST) research team which proves the efficacy of the medicine against the novel coronavirus.
FDA APPROVES FIRST HERBAL MEDICINE FOR CLINICAL TRIAL ON COVID-19 TREATMENT. pic.twitter.com/ZKEqrWWW1s— FDAGhana (@fdaghana) February 1, 2021
Delese Mimi Darko said after a detailed assessment of the application gave the requisite regulatory authorisation for the conduct of the trial.
“In the search for the treatment for the ongoing Covid-19 pandemic, researchers from the School of Public Health at the KNUST submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis Sanguinolenta as a potential treatment for covid-19.
“This follows results from the laboratory studies conducted by the KNUST research team which points in the direction of possible clinical benefits,” she noted
Under part 8 (section 150-166) of the Public Health Act 2012(Act 851), gives the authority the legal mandate to regulate clinical trials of drugs, herbal medicinal products, cosmetics or medical devices.
She revealed that the trail will be conducted at two sites.
Meanwhile, the Ghana Association of Medical Herbalists (GAMH) has confirmed that the herbal drug presented by KNUST for clinical trial, locally known as Nibima, is safe for human consumption when taken in the right dosage
“Nibima is very safe for human consumption. It has been there for so many years. In fact before even the Centre for Scientific Research into Plant Medicine made up their mind to use Nibima for medicine or research, people were already using it. It was safe. Over the years, scientists’ research has established that it is very safe for human consumption without any reported side effects to affect the organs once they are taken in the right quantity and in the right way”, he said.
He was positive that the efficacy of the Nibima herbal medicine is probably the reason why the KNUST is looking into it as a possible cure for covid-19 virus
Nibima plant holds enormous disease-healing properties
Studies conducted by the Centre for Plant Medicine Research in Mampong-Akuapim, show that the ‘nibima’ plant, scientifically called ‘Cryptolepsis sanguinolenta’ has vital properties for treatment of a number of diseases.
Crude extracts as well as the isolated alkaloidal constituents of the plant proved to have anti-malarial, anti-hypertensive and anti-hyperglycemic properties. This was contained in a press release issued by the Centre
It indicated that in-vitro studies showed that the plant had anti-microbial activity against Staphylococcus aureus, Escherichia coli, Candida albicans and other pathogens.The plant has over the years been used for the treatment of malaria, urinary tract infection and inflammatory conditions by some herbal medicine practitioners in the country.
Dr. Alfred Ampomah Appiah, a Principal Research Scientist and Deputy Executive Director of the Centre, who later spoke to the GNA, said the findings had proven right many of the traditional uses of the plant.
He added that ‘nibima’ held enormous potential for the development of essential medicines including anti-malarial agents. Complementary and alternative medicine practitioners in North America and Europe recommend the use of preparations of the plant for treatment of Lyme disease – an infection caused by bacteria, spread by ticks.